Cancer cell intrinsic TIM-3 induces glioblastoma progression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer cell intrinsic TIM-3 induces glioblastoma progression

Published:2022-11 Issue:11 Volume:25 Page:105329
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Guo Qing,Shen Shuai,Guan Gefei,Zhu Chen,Zou Cunyi,Cao Jingyuan,Cheng Wen,Xu Xiaoyan,Yu Juanhan,Lin Zhiguo,Wang Guoli,Chen Ling,Cheng Peng,Wu Anhua

Funder

Beijing Science and Technology Planning Project

National Natural Science Foundation of China

Chonnam National University

China Postdoctoral Science Foundation

Natural Science Foundation of Liaoning Province

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference59 articles.

1. Second-line treatments of small-cell lung cancers;Baize;Expert Rev. Anticancer Ther.,2017

2. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression;Becht;Genome Biol.,2016

3. A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer;Berns;Cancer Cell,2007

4. GlioVis data portal for visualization and analysis of brain tumor expression datasets;Bowman;Neuro Oncol.,2017

5. Extracellular vesicle-packaged HIF-1alpha-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells;Chen;Nat. Cell Biol.,2019

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-expression of immune checkpoints in glioblastoma revealed by single-nucleus RNA sequencing and spatial transcriptomics;Computational and Structural Biotechnology Journal;2024-12

2. Recent advances in biomimetic strategies for the immunotherapy of glioblastoma;Biomaterials;2024-12

3. Immune checkpoint pathways in glioblastoma: a diverse and evolving landscape;Frontiers in Immunology;2024-09-13

4. Suppressive immune microenvironment and CART therapy for glioblastoma: Future prospects and challenges;Cancer Letters;2024-09

5. Role of TIM-3 in ovarian cancer: the forsaken cop or a new noble;Frontiers in Immunology;2024-08-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3